Lung transplantation and bronchiolitis obliterans an evolution in understanding

Immunologic Research

Volumn 24, Issue 2, 2001, Pages 177-190

  McKane, Brice W ^a   Trulock, E P ^a   Patterson, G A ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchiolitis Obliterans; Immunopathogenesis; Lung Transplantation; Obliterative Bronchiolitis; Syndrome

Indexed keywords

ARTICLE; BRONCHIOLITIS; CELLULAR IMMUNITY; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; LUNG TRANSPLANTATION; MORBIDITY; MORTALITY; NONHUMAN; ORGAN DONOR; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ANIMALS; BRONCHIOLITIS OBLITERANS; DISEASE MODELS, ANIMAL; HISTOCOMPATIBILITY ANTIGENS; HUMANS; LUNG DISEASES, OBSTRUCTIVE; LUNG TRANSPLANTATION; MICE;

EID: 0034835424     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:24:2:177     Document Type: Article

References (53)

1. Technique of successful lung transplantation in humans
2. Pneumonectomy with replantation of the lung in the dog for physiologic study
3. The first transplantation of the lung in a human revisited
4. Lung homotransplantation in man
5. Problems in the management of human lung transplant patients
6. Improved bronchial healing in canine left lung reimplantation using omental pedicle wrap
7. A comparison between cyclosporin A and methylprednisolone plus azathioprine on bronchial healing following canine lung autotransplantation
8. Effects of methylprednisolone and azathioprine on bronchial healing following lung autotransplantation
9. Heart-lung transplantation. Successful therapy for patients with pulmonary vascular disease
10. Double-lung transplant for advanced chronic obstructive lung disease
11. Experimental en bloc double-lung transplantation
12. Experimental and clinical double-lung transplantation
13. Technical aspects of adult lung transplantation
14. Living-related donor lobectomy for bilateral lobar transplantation in patients with cystic fibrosis
15. Living-donor lobar lung transplantation experience: Intermediate results
16. Approach to management of the heartbeating "brain dead" organ donor
17. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation
18. Improved technique for bilateral lung transplantation: Rationale and initial clinical experience
19. Lung transplantation: A decade of experience
20. Results of single and bilateral lung transplantation in 131 consecutive recipients
21. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs
22. The registry of the international society of heart and lung transplantation: Thirteenth official report - 1996
23. Lung transplantation
24. Obliterative bronchiolitis after lung and heart-lung transplantation
25. Viability of stored lungs
26. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation
27. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation
28. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group
29. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts
30. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation
31. Bronchiolitis obliterans
32. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis
33. Expression of MHC antigens in normal human lungs and transplanted lungs with obliterative bronchiolitis
34. Presence of donor-specific alloreactivity in histologically normal lung allografts is predicative of subsequent bronchiolitis obliterans
35. Cytotoxic T lymphocytes directed against donor HLA class I antigens on airway epithelial cells are present in bronchoalveolar lavage fluid from lung transplant recipients during acute rejection
36. Indirect recognition of donor HLA class I peptides in lung transplantation recipients with bronchiolitis obliterans syndrome
37. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome
38. Effect of development of antibodies to HLA and CMV mismatch on lung transplant survival and development of bronchiolitis obliterans syndrome
39. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection
40. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation
41. Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation
42. Anti-HLA antibody binding to HLA class I molecules induces proliferation of airway epithelial cells: A potential mechanism for BOS
43. Endothelin-1 and cell proliferation in lung organ cultures
44. Insulinlike growth factor-1 in lung transplants with obliterative bronchiolitis
45. Early release of proinflammatory cytokines after lung transplantation
46. Expression of IL-6 in association with rat lung reimplantation and allograft rejection
47. Transforming growth factor beta (TGF-β) and obliterative bronchiolitis following pulmonary transplantation
48. Development of bronchiolitis obliterans syndrome despite blood chimerism in human lung transplant recipients
49. Lung allograft rejection in the rat
50. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways
51. The role of the CD40 pathway in alloantigen induced hyporesponsiveness in vivo
52. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants
53. Pulmonary retransplantation